Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare to Acquire Serologicals Celliance Unit for $3.7M in Bid to Boost Dx Reagent Play

NEW YORK, Nov. 29 (GenomeWeb News) - SeraCare Life Sciences will acquire Serologicals' Celliance subsidiary for $3.7 million in cash and "certain liabilities," the companies said today


SeraCare, based in Oceanside, Calif., will buy Celliance's Milford, Mass.-based diagnostic manufacturing facilities and its product lines.


Celliance, which in  October acquired gene-expression technology from Innovata, primarily offers products for cell culture and diagnostic applications. The acquisition is aimed at increasing SeraCare's footprint in molecular diagnostic reagents, diagnostic intermediates, and substrates, President and CEO Michael Crowley said in a statement.


The acquisition is expected to close in January, SeraCare said. Further details were not disclosed.


SeraCare has facilities in Cambridgeand Bridgewater, Mass.; Frederickand Gaithersburg, Md.; and Hatboro, Penn.It sells plasma-based therapeutic products, diagnostic products, and reagents; cell culture products; specialty plasmas; in vitro stabilizers; and a clinical sample repository for use in drug discovery and development.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.